|
Index of reports
> Cases resulting in death (34)
> Cases with Breast Cancer Metastatic (15)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in death where reactions include breast cancer metastatic.
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 2001-04-25
End date: 2002-08-07
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2001-02-01
End date: 2001-04-09
Prometrium
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2000-12-01
End date: 2000-12-15
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 2001-04-09
End date: 2002-07-26
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-22
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Cycrin
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-19
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Premarin
Dosage: unknown
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2001-01-01
Prefest
Ortho-EST
Provera
Dosage: unknown
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2001-01-01
Prempro
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-10
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Provera
Medroxyprogesterone Acetate
Premarin
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-09
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2000-12-01
Premarin
Dosage: unknown
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-09
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Dosage: unknown
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2000-12-01
Premarin
Dosage: unknown
Indication: Drug USE FOR Unknown Indication
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-10-03
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Dosage: unknown
Administration route: Oral
Start date: 1997-11-01
End date: 2001-04-01
Cycrin
Prempro
Medroxyprogesterone Acetate
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-06-22
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Prempro
Dosage: unknown
Start date: 1997-03-01
End date: 2000-05-01
Premarin
Dosage: unknown
Start date: 1995-06-01
End date: 1997-03-01
Provera
Dosage: unknown
Start date: 1995-06-01
End date: 1997-03-01
Adverse event in 61 year old female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-05-18
Patient: 61 year old female
Adverse reactions / side effects: Breast Cancer Metastatic, Oestrogen Receptor Assay Positive, Metastases TO Central Nervous System, Progesterone Receptor Assay Positive
Adverse event resulted in: death
Suspect drug(s):
Prempro
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Indication: Hormone Replacement Therapy
Provera
Indication: Hormone Replacement Therapy
Premarin
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-05-07
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Provera
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-04-27
Patient: female, weighing 80.8 kg (177.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Prempro
Provera
Premarin
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-03-09
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: death
Suspect drug(s):
Premarin
Indication: Oestrogen Replacement Therapy
Estrace
Indication: Hormone Replacement Therapy
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-03-07
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic, Breast Cancer Female
Adverse event resulted in: death
Suspect drug(s):
Estradiol
Dosage: oral
Administration route: Oral
Start date: 1985-01-01
End date: 1999-01-01
Premarin
Dosage: oral
Administration route: Oral
Start date: 1985-01-01
End date: 1995-01-01
Estrace
Dosage: oral
Administration route: Oral
Start date: 1985-01-01
End date: 1999-01-01
Adverse event in female receiving Premarin (Conjugated Estrogens)
Reported by a lawyer from United States on 2007-02-26
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic, Respiratory Arrest
Adverse event resulted in: death
Suspect drug(s):
Premarin
Provera
Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)
Reported by a consumer/non-health professional from United States on 2007-02-23
Patient: 53 year old female, weighing 90.7 kg (199.5 pounds)
Adverse reactions / side effects: Progesterone Receptor Assay Positive, Hepatitis, Cerebrovascular Accident, Breast Cancer Metastatic, Respiratory Failure, Oestrogen Receptor Assay Positive, Deep Vein Thrombosis, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Climara
Dosage: .05 mg/d, cont
Indication: Menopause
Start date: 1998-01-01
End date: 1998-01-01
Prempro
Dosage: 0.625/2.5 mg, unk
Indication: Menopause
Start date: 1997-01-01
End date: 1997-01-01
Medroxyprogesterone
Dosage: 2.5 mg, unk
Indication: Menopause
Start date: 1998-01-01
End date: 2000-01-01
Provera
Dosage: 2.5 mg, unk
Indication: Menopause
Start date: 1998-01-01
End date: 1998-01-01
Premarin
Dosage: 1.25 mg, unk
Indication: Menopause
Start date: 1998-01-01
End date: 1999-01-01
Other drugs received by patient: Kerlone; Xanax
|
